Oxford Immune Algorithmics

COVID-19 response
In response to the COVID-19 outbreak, we are offering Algocyte®, our rapid blood testing AI technology, to any NHS and health organisation that needs help monitoring the health and immune system of non-COVID-19 patients, at a highly subsidised cost.

Oxford Immune Algorithmics (OIA) is an award-winning bio and medtech company incubated by the University of Oxford which builds technology to move healthcare away from its reliance on population-wide symptom pattern matching toward value-based personalised diagnostics.

Based on model-driven machine learning developed by OIA, our flagship product, Algocyte, has the capacity to learn from each user’s immune system, enabling patients and doctors to take more timely, safer and better-informed decisions.

OIA's products expand current trends in telemedicine, moving from online medical appointments to smart remote blood testing for immune health monitoring.

The OIA team consists of a group of professionals with advanced degrees in science and medicine. Affiliated with OIA and the universities of Oxford, Cambridge and the Karolinska Institute, the team has published more than 200 papers in top-ranked journals in the areas of Artificial Intelligence, computational medicine and immunology.

CE compliant under the European Medical Devices Directive UK MHRA Registration No. 09450
Harmonised ISO 13485, ISO 14971/DCB0129
Patents pending GB1918948.9, GB2020375.8 and PCT/GB2020/05328

Pandemic-ready

Algocyte® is particularly useful to vulnerable patients who may put themselves at risk of infection (e.g. COVID-19) when visiting hospitals or when forced to delay their treatment because they cannot be properly monitored before or after an intervention.

A world free of preventable diseases

The mission of Algocyte® is to help transform healthcare from a discipline that is heavily based upon statistical symptom pattern-matching into one centred on personal patient model-driven causal early diagnosis by exploiting the cutting-edge research on immunology, causality in cell biology, and biological complexity that our team has pioneered at some of the world's best research universities.

Read the feedback from patients and doctors Why Use Algocyte?

Algocyte® is OIA's flagship product, a medically-driven solution that exploits the power of responsible AI to help patients and doctors. Doctors can remotely monitor the health and immune system of their patients who can test themselves and record their health information safely at home.

Algocyte's features are proven to be of even greater vital importance in the context of the COVID-19 pandemic:

Reduction of hospital/clinic visits & infection risks
Better outcome from personalised immune profiles & reference values (learning from the individual patient)
Higher ‘Standard of care’ delivered remotely
Early detection of ‘slow trends and rapid changes
Aggregation and incorporation of other user’s medical data (e.g. biochem and omics)
Automation & data saves doctors ~2-3 hrs/wk (patient triage, smart treatment comparison, and results’ flagging) - allowing them to spend more time with patients*
* independently verified from a survey conducted by NHS Medici Practice in the North of London, July 2020

AI can help make medicine more human by giving doctors the gift of time.

Algocyte® relieves clinicians of time-consuming tasks, of critical importance when dealing with large backlogs inherited from shortage of medical staff or the pandemic emergency. It also enables clinicians to deliver regular contact and care, and healthcare organisations to reduce pressure on their limited resources.

Request more information or a demonstration

Screenshots of Algocyte, a full rapid remote blood testing end-to-end solution that includes an app (also desktop available) with
two-way meaningful communication capabilities between patient and doctor matching symptoms and adverse effects to tests also performed with Algocyte at home.

Bridging the academy & industry

With over two thousand members, our AI meetup groups in the UK are among the largest in their respective cities and demonstrate our commitment to connecting the academic and industrial communities and bringing responsible AI to healthcare: